NIKISHA JONES: Open Payments
NPI 1336208800 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 19 payments from 11 companies in 2025. Trend: 2023 $574 · 2024 $55 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 2 | $157 |
| Alnylam Pharmaceuticals Inc. | 3 | $97 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
| ABIOMED | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: Barostim Neo System, AMVUTTRA, ENTRESTO, VERQUVO, WINREVAIR, INJECTAFER, CARDIOMEMS, JARDIANCE.
Industry payments across GA — which companies pay providers there.
